Nasus Pharma Stock Plummets Following Phase 2 Study Results
Shares of Nasus Pharma Ltd. (AMEX:NSRX) experienced a significant decline on Monday, dropping to a new 52-week low of $2.82. This sharp decrease followed the announcement of topline results from…